Advertisement

AIDS and Behavior

, Volume 17, Issue 6, pp 2237–2243 | Cite as

Feasibility of Interactive Text message Response (ITR) as a Novel, Real-Time Measure of Adherence to Antiretroviral Therapy for HIV+ Youth

  • Nadia Dowshen
  • Lisa M. Kuhns
  • Camdin Gray
  • Susan Lee
  • Robert Garofalo
Brief Report

Abstract

Youth living with HIV/AIDS (YLH) face unique challenges to optimal adherence to antiretroviral therapy (ART). Accurate, real-time methods to assess adherence are needed to facilitate early intervention and promote viral suppression. The purpose of this study was to assess the feasibility and validity of interactive text message response (ITR) as a measure of adherence to ART among YLH. This study was part of a larger pilot text message reminder intervention conducted at a US community-based, LGBT-focused health center providing clinical services to YLH. Eligibility criteria for this pilot study included HIV-positive serostatus, aged 14–29, use of personal cell phone, English-speaking, and on ART with demonstrated adherence difficulties. During the 24-week study period, participants received personalized daily short message system reminders with a follow-up message 1 hour later asking whether they took medication and directing a response via return text message. To determine whether or not ITR would be a feasible, valid measure of adherence, we calculated the proportion of positive responses indicating medication had been taken divided by the total number of messages requesting a response and compared this response rate to a self-reported adherence measure, the visual analogue scale (VAS). Participants (n = 25) were on average 23 years old, largely male (92 %), Black (60 %) and behaviorally infected (84 %). Over the course of the intervention, study participants responded to prompts via text to indicate whether or not they had taken their medication approximately 61 % of the time. The overall mean ITR adherence rate (i.e., positive responses) was 57.4 % (SD = 28.5 %). ITR and VAS measures were moderately, positively correlated (r = 0.52, p < 0.05) during the first 6 weeks of the study period. ITR adherence rates were significantly higher on weekdays versus weekends (p < 0.05). This pilot study showed both moderate responsiveness of individuals to daily ITR and a moderate correlation of ITR adherence rates with a reliable measure during the first 6 weeks of the study, suggesting that this method, with additional effort and improvements, may be a helpful tool to identify and respond to adherence patterns in real-time.

Keywords

Adolescents HIV/AIDS Adherence Text messaging Short message system (SMS) Mobile health intervention 

Notes

Acknowledgments

The authors would like to acknowledge the Howard Brown Health Center research and clinical staff, and Intelecare for their support of this study.

References

  1. 1.
    Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA. 2008;300(5):520–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Centers for Disease Control and Prevention. HIV amoung youth. In: Division of HIV/AIDS Prevention, editor. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Atlanta 2011. p. 2. http://www.cdc.gov/hiv/youth/pdf/youth.pdf.
  3. 3.
    Flynn P, Rudy B, Douglas S, et al. Virologic and immunologic outcomes after 24 weeks in HIV type 1-infected adolescents receiving highly active antiretroviral therapy. J Infect Dis. 2004;190(2):271–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Gross R, Bilker WB, Friedman HM, Strom BL. Effect of adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS. 2001;15(16):2109–17.PubMedCrossRefGoogle Scholar
  5. 5.
    Paterson D, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30.PubMedCrossRefGoogle Scholar
  6. 6.
    Quinn T, Wawer M, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000;342(13):921–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Tang J, Pillay D. Transmission of HIV-1 drug resistance. J Clin Virol. 2004;30(1):1–10.PubMedCrossRefGoogle Scholar
  8. 8.
    Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis. 2000:S171–S6.Google Scholar
  9. 9.
    Woods SP, Ludicello JE, Moran LM, Carey CL, Dawson, Grant I. HIV-associated prospective memory impairment increases risk of dependence in everyday functioning. Neuropsychology. 2008;22(1):110–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Belzer M, Fuchs DN, Luftman GS, Tucker DJ. Antiretroviral adherence issues among HIV-positive adolescents and young adults. J Adolesc Health. 1999;25:316–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Murphy D, Wilson C, Durako S, Muenz L, Belzer M. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care. 2001;13(1):27–40.PubMedCrossRefGoogle Scholar
  12. 12.
    Naar-King S, Templin T, Wright K, Frey M, Parsons J, Lam P. Psychosocial factors and medication adherence in HIV-positive youth. AIDS Patient Care STDs. 2006;20(1):44–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Rao D, Kekwaletswe T, Hosek S, Martinez J, Rodriguez F. Stigma and social barriers to medication adherence with urban youth living with HIV. AIDS Care. 2007;19(1):28–33.PubMedCrossRefGoogle Scholar
  14. 14.
    Thompson MA, Mugavero MJ, Amico KR, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med. 2012;156(11):817–33, W-284, W-5, W-6, W-7, W-8, W-9, W-90, W-91, W-92, W-93, W-94.Google Scholar
  15. 15.
    Heron KE, Smyth JM. Ecological momentary interventions: incorporating mobile technology into psychosocial and health behaviour treatments. Br J Health Psychol. 2010;15(Pt 1):1–39.PubMedCrossRefGoogle Scholar
  16. 16.
    Rodgers A, Corbett T, Bramley D, et al. Do u smoke after txt? Results of a randomised trial of smoking cessation using mobile phone text messaging. Tob Control. 2005;14(4):255–61.PubMedCrossRefGoogle Scholar
  17. 17.
    Shiffman S. Dynamic influences on smoking relapse process. J Pers. 2005;73(6):1715–48.PubMedCrossRefGoogle Scholar
  18. 18.
    Shiffman S, Stone AA, Hufford MR. Ecological momentary assessment. Annu Rev Clin Psychol. 2008;4:1–32.PubMedCrossRefGoogle Scholar
  19. 19.
    CTIA-The Wireless Association. U.S. wireless quick facts: 2011 year-end figures. Washington, DC. http://www.ctia.org/advocacy/research/index.cfm/aid/103232012.
  20. 20.
    Lenhart A, Ling R, Campbell S, Purcell K. Teens and mobile phones. : Washington, DC: Pew Internet & American Life Project; 2010. http://www.pewinternet.org/~/media/.
  21. 21.
    Franklin V, Waller A, Pagliari C, Greene S. “Sweet Talk”: text messaging support for intensive insulin therapy for young people with diabetes. Diabetes Technol Ther. 2003;5(6):991–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Franklin VL, Waller A, Pagliari C, Greene SA. A randomized controlled trial of Sweet Talk, a text-messaging system to support young people with diabetes. Diabet Med. 2006;23(12):1332–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Hung SH, Tseng HC, Tsai WH, Lin HH, Cheng JH, Chang YM. Care for asthma via mobile phone (CAMP). Stud Health Technol Inform. 2007;126:137–43.PubMedGoogle Scholar
  24. 24.
    Miloh T, Annunziato R, Arnon R, et al. Improved adherence and outcomes for pediatric liver transplant recipients by using text messaging. Pediatrics. 2009;124(5):e844–50.PubMedCrossRefGoogle Scholar
  25. 25.
    Neville R, Greene A, McLeod J, Tracy A, Surie J. Mobile phone text messaging can help young people manage asthma. BMJ (Clinical research ed). 2002;325(7364):600.CrossRefGoogle Scholar
  26. 26.
    Pearson CR, Simoni JM, Hoff P, Kurth AE, Martin DP. Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues. AIDS Behav. 2007;11(2):161–73.PubMedCrossRefGoogle Scholar
  27. 27.
    Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA. 1989;261(22):3273–7.PubMedCrossRefGoogle Scholar
  28. 28.
    Haberer JE, Robbins GK, Ybarra M, et al. Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable. AIDS Behav. 2012;16(2):375–82.PubMedCrossRefGoogle Scholar
  29. 29.
    Dowshen N, Kuhns LM, Johnson A, Holoyda BJ, Garofalo R. Improving adherence to antiretroviral therapy for youth living with HIV/AIDS: a pilot study using personalized, interactive, daily text message reminders. J Med Internet Res. 2012;14(2):e51.PubMedCrossRefGoogle Scholar
  30. 30.
    Derogatis LR. Brief Symptom Inventory-18: adminstration, scoring, and procedure manual. Minneapolis: National Computer Systems Inc; 2000.Google Scholar
  31. 31.
    Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med. 1983;13(3):595–605.PubMedCrossRefGoogle Scholar
  32. 32.
    Winters K, Zenilman J. Simple screening instrument for outreach for alcohol and other drug abuse and infectious diseases (Vol. 11, Publication No. (SMA) 02-3683). Rockville: Center for Substance Abuse Treatment: US Department of Health and Human Services (SAMHSA); 1994.Google Scholar
  33. 33.
    Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg DR. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials. 2004;5(2):74–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000;12(3):255–66.PubMedCrossRefGoogle Scholar
  35. 35.
    Garfield S, Clifford S, Eliasson L, Barber N, Willson A. Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review. BMC Med Res Methodol. 2011;11:149.PubMedCrossRefGoogle Scholar
  36. 36.
    Haberer JE, Kiwanuka J, Nansera D, Wilson IB, Bangsberg DR. Challenges in using mobile phones for collection of antiretroviral therapy adherence data in a resource-limited setting. AIDS and behavior. 2010;14(6):1294–301.PubMedCrossRefGoogle Scholar
  37. 37.
    Pop-Eleches C, Thirumurthy H, Habyarimana JP, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011;25(6):825–34.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Nadia Dowshen
    • 1
    • 2
  • Lisa M. Kuhns
    • 3
    • 4
  • Camdin Gray
    • 3
  • Susan Lee
    • 1
  • Robert Garofalo
    • 3
    • 4
  1. 1.Craig-Dalsimer Division of Adolescent MedicineThe Children’s Hospital of PhiladelphiaPhiladelphiaUSA
  2. 2.Perelman School of MedicineUniversity of PennsylvaniaPhiladelphiaUSA
  3. 3.Division of Academic General PediatricsAnn & Robert H. Lurie Children’s Hospital of ChicagoChicagoUSA
  4. 4.Feinberg School of MedicineNorthwestern UniversityChicagoUSA

Personalised recommendations